US Broker Ratings

AxoGen, Inc. (AXGN) Stock Analysis: Exploring a Promising 16.32% Upside in the Healthcare Sector

AxoGen, Inc. (NASDAQ: AXGN) stands out as a noteworthy player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $2.96..

Butterfly Network, Inc. (BFLY) Stock Analysis: Investors Eye 48.69% Potential Upside

In the rapidly evolving healthcare sector, Butterfly Network, Inc. (NASDAQ: BFLY) is making waves with its cutting-edge medical devices, capturing the attention of investors looking for..

SI-BONE, Inc. (SIBN)

⚠️ No article content returned.

..

Xencor, Inc. (XNCR) Stock Analysis: Navigating a 42% Upside Potential with Strong Buy Ratings

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company, has been capturing the interest of investors with its robust pipeline focused on engineered antibodies for cancer and..

Evolus, Inc. (EOLS) Stock Analysis: Strong Analyst Ratings and Almost 100% Upside Potential

Evolus, Inc. (NASDAQ: EOLS), a prominent player in the healthcare sector, specifically within the drug manufacturers – specialty & generic industry, is catching investor attention with..

Oculis Holding AG (OCS) Stock Analysis: A 351% Potential Upside in the Biotech Arena

Investors eyeing opportunities in the biotechnology sector should take a closer look at Oculis Holding AG (OCS), a Switzerland-based clinical-stage biopharmaceutical company. With a remarkable analyst..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Exploring a Potential 95% Upside in the Biotech Sector

Investors with a keen interest in biotechnology may find Maze Therapeutics, Inc. (NASDAQ: MAZE) an intriguing prospect. With a market capitalization of $1.77 billion, Maze Therapeutics..

Altimmune, Inc. (ALT) Stock Analysis: Exploring the Potential 699.58% Upside

Altimmune, Inc. (NASDAQ: ALT), a promising player in the biotechnology sector, is capturing investor attention with its ambitious focus on novel therapies for serious liver diseases...

Taysha Gene Therapies (TSHA) Stock Report: Exploring the 208% Upside Potential

Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is capturing the attention of investors with its ambitious focus on developing adeno-associated virus-based gene therapies for severe monogenic diseases..

Auna SA (AUNA) Stock Analysis: Healthcare Giant’s 45% Potential Upside Beckons Investors

Auna SA (AUNA), a significant player in the healthcare sector, has attracted investor attention with a potential upside of 45.54%. Operating hospitals and clinics across Mexico,..

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: A Biotech Gem with 143% Potential Upside

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is making waves in the biotechnology sector, particularly for investors seeking high-growth opportunities within the healthcare industry. With a market capitalization..

Kura Oncology, Inc. (KURA) Stock Analysis: Uncovering a 201% Upside in the Biotech Landscape

Kura Oncology, Inc. (NASDAQ: KURA), a prominent player in the biotechnology sector, is catching the eye of investors with a potential upside of over 201%. Situated..

Rocket Pharmaceuticals (RCKT) Stock Analysis: Exploring a 237% Potential Upside in Gene Therapy Innovations

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stands at the forefront of genetic therapy innovation, targeting rare and devastating diseases. As a late-stage biotechnology company, Rocket Pharmaceuticals is..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: A Rare Disease Focus with 33% Potential Upside

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a burgeoning player in the healthcare sector, is capturing investor attention with its impressive growth metrics and substantial upside potential. Specializing..

Weave Communications, Inc. (WEAV) Stock Analysis: Evaluating Growth in the Health Information Services Sector

Weave Communications, Inc. (WEAV) has firmly positioned itself within the burgeoning Health Information Services industry, offering a suite of AI-powered tools tailored for small and medium-sized..

Immunome, Inc. (IMNM) Stock Analysis: A Look at the 93% Potential Upside in the Biotech Sector

Immunome, Inc. (NASDAQ: IMNM), a biotechnology company focused on developing innovative oncology therapeutics, is drawing significant attention from investors due to its remarkable potential upside of..

Tectonic Therapeutic, Inc. (TECX): Investor Outlook with a Promising 246% Potential Upside

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a burgeoning name in the biotechnology sector, is capturing investor attention with its innovative approach to drug discovery and development. Headquartered..

Sana Biotechnology, Inc. (SANA): Investor Outlook on Potential 209.87% Upside

Sana Biotechnology, Inc. (NASDAQ: SANA) has captured the attention of investors with its ambitious approach to cellular engineering in the healthcare sector. As a key player..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Exploring a Potential 425% Upside in Healthcare Innovation

Sionna Therapeutics, Inc. (NASDAQ: SION), a clinical-stage biopharmaceutical company, is currently capturing investor attention with its promising portfolio in the biotechnology sector, particularly in the treatment..

Praxis Precision Medicines, Inc (PRAX): Investor Outlook Reveals 125% Potential Upside

Praxis Precision Medicines, Inc. (NASDAQ: PRAX) presents a compelling opportunity for investors looking to venture into the healthcare sector, particularly within the biotechnology industry. Headquartered in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds